An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki's ...

In the second quarter, J&J’s worldwide oncology sales shot up more than 20 per cent, offsetting declines in sales of its ...

Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my ...

J&J (NYSE:JNJ) stock surges rallying peers despite Trump's latest tariff threats on pharma as the company posts a quarterly ...

A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...

President Donald Trump is keeping up the pace with seemingly a new tariff development every day. This time, he flagged that ...

A Nigerian-born health data scientist, David Ajayi, is making waves in the United States through nationally recognized work ...

GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity or type 2 diabetes, researchers reported in San Francisco at ENDO 2025, the ...

President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...

Fort Wayne was No. 24 on LinkedIn’s list. LinkedIn called Fort Wayne a “city on the rise” because “a wave of new investments in data centers and tech infrastructure, coupled with affordable housing ...

Two Republican senators and a broad coalition of funders made a big difference for private foundations during negotiations ...

Illustrating its confidence in its proprietary products, the Southern California company has announced an ambitious plan to ...